OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CLIS$28860.0058

CLIS.TA

Multiline Insurance & BrokersVerified

The company's capital structure is characterized by a high debt-to-equity ratio of 1.43, indicating a significant reliance on debt financing. Despite a negative operating income of -12.34 billion ILS, the company reported a net income of 2.28 billion ILS, suggesting effective cost management or non-operating income sources. The return on equity of 21.04% is notably high, indicating strong profitability relative to shareholders' equity. In terms of profitability, the company's return on assets of 1.21% is relatively low compared to industry standards, suggesting that the company is not efficiently utilizing its assets to generate profits. The price-to-earnings ratio of 1023.6 is extremely high, indicating that the market is valuing the company's earnings at a premium, which may not be sustainable. The price-to-book ratio of 215.37 also suggests that the market is willing to pay a significant premium for the company's book value. The company's revenue is primarily concentrated in the insurance and asset management segments, with no significant geographic diversification mentioned in the available data. The operating cash flow of 2.51 billion ILS and free cash flow of 2.19 billion ILS indicate that the company is generating substantial cash from its operations, which can be used for reinvestment or debt reduction. The company's growth trajectory is uncertain, as the available data does not provide specific revenue growth figures for the current or next fiscal year. However, the high debt-to-equity ratio and negative net cash position after subtracting total debt suggest potential liquidity risks. The risk assessment indicates a medium liquidity risk and a low dilution risk, suggesting that the company is not currently facing significant pressure to issue new shares. Recent events and filings do not provide specific details on the company's strategic initiatives or market conditions affecting its operations. The analyst estimates suggest a strong buy recommendation with a mean price target of 290.00 ILS, indicating positive sentiment among analysts.

30-day price · CLIS+3710.00 (+14.8%)
Low$23670.00High$29900.00Close$28860.00As of27 May, 00:00 UTC
Profile
CompanyCLIS.TA
TickerCLIS.TA
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryMultiline Insurance & Brokers
AI analysis

Business. CLIS.TA operates in the insurance and asset management sectors, providing multiline insurance and brokerage services.

Classification. The company is classified under the Financials economic sector, Insurance business sector, and Multiline Insurance & Brokers industry with a confidence level of 0.92.

The company's capital structure is characterized by a high debt-to-equity ratio of 1.43, indicating a significant reliance on debt financing. Despite a negative operating income of -12.34 billion ILS, the company reported a net income of 2.28 billion ILS, suggesting effective cost management or non-operating income sources. The return on equity of 21.04% is notably high, indicating strong profitability relative to shareholders' equity. In terms of profitability, the company's return on assets of 1.21% is relatively low compared to industry standards, suggesting that the company is not efficiently utilizing its assets to generate profits. The price-to-earnings ratio of 1023.6 is extremely high, indicating that the market is valuing the company's earnings at a premium, which may not be sustainable. The price-to-book ratio of 215.37 also suggests that the market is willing to pay a significant premium for the company's book value. The company's revenue is primarily concentrated in the insurance and asset management segments, with no significant geographic diversification mentioned in the available data. The operating cash flow of 2.51 billion ILS and free cash flow of 2.19 billion ILS indicate that the company is generating substantial cash from its operations, which can be used for reinvestment or debt reduction. The company's growth trajectory is uncertain, as the available data does not provide specific revenue growth figures for the current or next fiscal year. However, the high debt-to-equity ratio and negative net cash position after subtracting total debt suggest potential liquidity risks. The risk assessment indicates a medium liquidity risk and a low dilution risk, suggesting that the company is not currently facing significant pressure to issue new shares. Recent events and filings do not provide specific details on the company's strategic initiatives or market conditions affecting its operations. The analyst estimates suggest a strong buy recommendation with a mean price target of 290.00 ILS, indicating positive sentiment among analysts.
Key takeaways
  • The company has a high debt-to-equity ratio, indicating a significant reliance on debt financing.
  • Despite a negative operating income, the company reported a positive net income, suggesting effective cost management or non-operating income sources.
  • The company's return on equity is high, but the return on assets is relatively low, indicating inefficiencies in asset utilization.
  • The company's market valuation is extremely high, as indicated by the price-to-earnings and price-to-book ratios.
  • The company's liquidity risk is medium, and the dilution risk is low, suggesting no immediate pressure to issue new shares.
  • ## RATIONALES
  • **margin_outlook_rationale**: The company's margin outlook is uncertain due to the negative operating income and low return on assets.
  • **rd_outlook_rationale**: No specific information is available on the company's research and development activities.
Financial snapshot
PeriodHA-latest
CurrencyILS
Revenue
Gross profit
Operating income-$12.34B
Net income$2.28B
R&D
SG&A
D&A
SBC
Operating cash flow$2.51B
CapEx-$403.0M
Free cash flow$2.19B
Total assets$188.36B
Total liabilities$177.53B
Total equity$10.83B
Cash & equivalents$4.59B
Long-term debt$15.46B
Valuation
Market price$28860.00
Market cap$2.33T
Enterprise value$2.34T
P/E1023.6
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF932.2
P/B215.4
P/Tangible book215.4
Tangible book$10.83B
Net cash-$10.88B
Current ratio
Debt/Equity1.4
ROA1.2%
ROE21.0%
Cash conversion1.1%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Asset Management · cohort 27 companies
MetricCLISActivity
Op margin10.7% medp25 0.3% · p75 28.3%
Net margin6.3% medp25 -0.8% · p75 18.8%
Gross margin47.8% medp25 32.7% · p75 78.3%
CapEx / revenue-2.6% medp25 -5.5% · p75 -0.8%
Debt / equity143.0%4.4% medp25 0.0% · p75 36.0%top quartile
Observations
IR observations
Mean price target290.00 ILS
Median price target290.00 ILS
High price target290.00 ILS
Low price target290.00 ILS
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate27.38 ILS
Last actual EPS27.47 ILS
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 17:20 UTC#f79d5877
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 15:57 UTCJob: 2cce5a48